Growth Metrics

Electromed (ELMD) Cash & Equivalents (2016 - 2025)

Electromed (ELMD) has disclosed Cash & Equivalents for 16 consecutive years, with $13.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 15.05% to $13.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.8 million, a 15.05% decrease, with the full-year FY2025 number at $15.3 million, down 4.93% from a year prior.
  • Cash & Equivalents was $13.8 million for Q4 2025 at Electromed, down from $14.1 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $16.2 million in Q4 2024 to a low of $6.0 million in Q3 2022.
  • A 5-year average of $11.2 million and a median of $11.3 million in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 45.37% in 2022, then skyrocketed 118.12% in 2024.
  • Electromed's Cash & Equivalents stood at $10.5 million in 2021, then tumbled by 34.01% to $6.9 million in 2022, then surged by 51.02% to $10.4 million in 2023, then soared by 55.6% to $16.2 million in 2024, then dropped by 15.05% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for ELMD's Cash & Equivalents are $13.8 million (Q4 2025), $14.1 million (Q3 2025), and $15.3 million (Q2 2025).